EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, synthesis, and theoretical studies of sulfonylated purine derivatives as EGFR inhibitor

Vivekananda Saha, Sritama Chakraborty, Priya Modak, Papiya Sarkar, Souvik Sarkar, Soma Das Pradhan, Subhadeep Sen, Prasun Kanti Pradhan, Goutam Biswas

Current Proteomics · 2025-02 · 22 (1) · 100004

DOI: 10.1016/j.curpro.2025.100004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Proteomics, 2025-02. Verfasst von Vivekananda Saha und 8 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Grants Commission.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • University Grants Commission

Zitieren

APA

Saha, V., Chakraborty, S., Modak, P., Sarkar, P., Sarkar, S., Pradhan, S. D., Sen, S., Pradhan, P. K., & Biswas, G. (2025). Design, synthesis, and theoretical studies of sulfonylated purine derivatives as EGFR inhibitor. Current Proteomics, 22(1), 100004. https://doi.org/10.1016/j.curpro.2025.100004

Vancouver

Saha V, Chakraborty S, Modak P, Sarkar P, Sarkar S, Pradhan SD, et al. Design, synthesis, and theoretical studies of sulfonylated purine derivatives as EGFR inhibitor. Current Proteomics. 2025;22(1):100004. doi:10.1016/j.curpro.2025.100004

BibTeX
@article{Saha2025,
  author = {Saha, Vivekananda and Chakraborty, Sritama and Modak, Priya and Sarkar, Papiya and Sarkar, Souvik and Pradhan, Soma Das and Sen, Subhadeep and Pradhan, Prasun Kanti and Biswas, Goutam},
  title = {Design, synthesis, and theoretical studies of sulfonylated purine derivatives as EGFR inhibitor},
  journal = {Current Proteomics},
  year = {2025},
  volume = {22},
  number = {1},
  pages = {100004},
  doi = {10.1016/j.curpro.2025.100004}
}
Kostenlos starten →